Overview

• Madhya Pradesh police detained Sresan Pharma owner Ranganathan in Chennai in the Coldrif case after announcing a cash reward for information.
• Tamil Nadu’s state laboratory confirmed diethylene glycol in Coldrif samples, declaring the product adulterated.
• The Tamil Nadu Drug Control Department halted production at the Sresan facility, seized stocks, began canceling the manufacturing licence, and issued distribution alerts to other states.
• Two more child deaths in Madhya Pradesh raised the toll to 22, as an SIT was formed and a local doctor was arrested on alleged negligence.
• Separate Rajasthan documents showed widespread quality failures in marketed generics with thousands of failed units sold, and the state drug controller was suspended over an allegedly suppressed report.